AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 92 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $108,128 | +211.8% | 94,849 | +150.2% | 0.00% | – |
| Q2 2023 | $34,681 | -22.9% | 37,903 | -53.5% | 0.00% | – |
| Q1 2023 | $45,000 | +2249900.0% | 81,547 | +1916.5% | 0.00% | – |
| Q4 2022 | $2 | -100.0% | 4,044 | -64.5% | 0.00% | – |
| Q3 2022 | $4,000 | +33.3% | 11,391 | +57.8% | 0.00% | – |
| Q2 2022 | $3,000 | -99.9% | 7,220 | -99.8% | 0.00% | – |
| Q1 2022 | $3,057,000 | -69.5% | 4,258,198 | -3.9% | 0.00% | -100.0% |
| Q4 2021 | $10,017,000 | -23.8% | 4,432,203 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $13,150,000 | -29.9% | 4,565,735 | -7.7% | 0.00% | 0.0% |
| Q2 2021 | $18,753,000 | +360.5% | 4,947,777 | +311.3% | 0.00% | +100.0% |
| Q1 2021 | $4,072,000 | -0.3% | 1,203,017 | -17.5% | 0.00% | 0.0% |
| Q4 2020 | $4,086,000 | +651.1% | 1,458,824 | +540.0% | 0.00% | – |
| Q3 2020 | $544,000 | -82.9% | 227,951 | -2.5% | 0.00% | -100.0% |
| Q2 2020 | $3,175,000 | -12.7% | 233,803 | -51.3% | 0.00% | 0.0% |
| Q1 2020 | $3,638,000 | +100.4% | 479,997 | +67.2% | 0.00% | – |
| Q4 2019 | $1,815,000 | +50.5% | 287,090 | -6.6% | 0.00% | – |
| Q3 2019 | $1,206,000 | -11.6% | 307,390 | +4.3% | 0.00% | – |
| Q2 2019 | $1,365,000 | -40.5% | 294,813 | +5.3% | 0.00% | – |
| Q1 2019 | $2,293,000 | +47.5% | 279,944 | -0.5% | 0.00% | – |
| Q4 2018 | $1,555,000 | -42.4% | 281,328 | -8.0% | 0.00% | -100.0% |
| Q3 2018 | $2,699,000 | -8.9% | 305,693 | +2.9% | 0.00% | 0.0% |
| Q2 2018 | $2,963,000 | +14.4% | 296,946 | +9.3% | 0.00% | 0.0% |
| Q1 2018 | $2,589,000 | -39.2% | 271,673 | -5.1% | 0.00% | 0.0% |
| Q4 2017 | $4,256,000 | +3537.6% | 286,257 | +2162.9% | 0.00% | – |
| Q1 2017 | $117,000 | -79.7% | 12,650 | -77.2% | 0.00% | – |
| Q4 2016 | $576,000 | +5660.0% | 55,368 | +4185.4% | 0.00% | – |
| Q2 2016 | $10,000 | +100.0% | 1,292 | +156.3% | 0.00% | – |
| Q1 2016 | $5,000 | +150.0% | 504 | +273.3% | 0.00% | – |
| Q4 2015 | $2,000 | – | 135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |